CTEP conducts a variety of clinical trials, including:
Phase I trials to assess the safety and optimal dosing of new treatments. Phase II trials to evaluate the efficacy of these treatments in specific cancer types. Phase III trials to compare new treatments with standard therapies in larger patient populations. Biomarker-driven trials to identify which patients are most likely to benefit from specific therapies. Combination therapy trials to investigate the effectiveness of combining different treatments.
